Jenburkt Pharmaceuticals Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Jenburkt Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 5 May 2026, inter alia, have recommended the final dividend of Rs 20.7 per equity Share (i.e. 207%) , subject to the approval of the shareholders.

Jenburkt Pharmaceuticals announced that the 41th Annual General Meeting(AGM) of the company will be held on 4 September 2026.

Net profit of Jenburkt Pharmaceuticals rose 27.05% to Rs 10.85 crore in the quarter ended March 2026 as against Rs 8.54 crore during the previous quarter ended March 2025. Sales rose 8.72% to Rs 44.63 crore in the quarter ended March 2026 as against Rs 41.05 crore during the previous quarter ended March 2025.

For the full year,net profit rose 8.36% to Rs 34.74 crore in the year ended March 2026 as against Rs 32.06 crore during the previous year ended March 2025. Sales rose 11.24% to Rs 168.74 crore in the year ended March 2026 as against Rs 151.69 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 May 2026.